NCCTG N0872 (Alliance): A Randomized Placebo-Controlled Phase II Trial of Bevacizumab Plus Dasatinib in Patients with Recurrent Glioblastoma (GBM)
- Citation:
- J Clin Oncol vol 33 (suppl) abstr 2004
- Meeting Instance:
- ASCO 2015
- Year:
- 2015
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3008
- Pharmas:
- Grants:
- U10CA 25224-32, U10CA180821, U10CA180882
- Corr. Author:
- Galanis
- Authors:
- Evanthia Galanis S. Keith Anderson Panagiotis Z. Anastasiadis David Tran Suriya A. Jeyapalan Daniel M. Anderson Tim Kaufmann Caterina Giannini Jan C. Buckner David Schiff
- Networks:
- LAPS-MN026, LAPS-MO011, METROMIN, RI005, VA009
- Study
- NCCTG-N0872
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: